Mei-Shi Announces Board Decision to Cancel Fund Lending to Subsidiary
Key facts
- Mei-Shi Announces Board Decision to Cancel Fund Lending to Subsidiary
- Mei-Shi Chemical Pharmaceutical Co., Ltd. has announced that its board has approved the cancellation of a USD 20 million fund lending arrangement to its subsidiary, Lotus International Pte. Ltd., citing operational adjustments.
- Source: PR Times
- Date: June 27, 2026
Direct answer
Mei-Shi Chemical Pharmaceutical Co., Ltd. has announced that its board has approved the cancellation of a USD 20 million fund lending arrangement to its subsidiary, Lotus International Pte. Ltd., citing operational adjustments.
- Citation
- Mei-Shi Announces Board Decision to Cancel Fund Lending to Subsidiary (June 27, 2026), PR Times
- Source
- PR Times
- Date
- June 27, 2026
Mei-Shi Chemical Pharmaceutical Co., Ltd. has announced that its board has approved the cancellation of a USD 20 million fund lending arrangement to its subsidiary, Lotus International Pte. Ltd., citing operational adjustments.
📋 Article Processing Timeline
- 📰 Published: June 27, 2026 at 09:00
- 🔍 Collected: June 28, 2026 at 00:08 (15h 8m after Published)
- 🤖 AI Analyzed: June 28, 2026 at 00:11 (2 min after Collected)
Disclosure Date: June 27, 2026
Statement Date: June 26, 2026
Statement Time: 19:45:55
Company Code: 1795
Company Name: Mei-Shi Chemical Pharmaceutical Co., Ltd.
Subject: Announcement of Board Resolution to Cancel Fund Lending to Subsidiary Lotus International Pte. Ltd.
Applicable Clause: Item 51
Factual Date: June 26, 2026
Details:
1. Factual Date: June 26, 2026
2. Company Name: Mei-Shi Chemical Pharmaceutical Co., Ltd.
3. Relationship with Company: Parent Company
4. Cross-shareholding Ratio: 100%
5. Reason for Event: In alignment with the company's current operational status, the board has decided to cancel the previously approved USD 20 million fund lending limit to its subsidiary, Lotus International Pte. Ltd.
6. Countermeasures: Not applicable
7. Other Matters to be Disclosed: This announcement qualifies as material information under Article 7, Clause 9 of the Enforcement Rules of the Securities and Exchange Act, as the entity involved is a publicly listed company. However, there are no additional matters requiring disclosure that would significantly impact shareholder权益 or securities prices.
Statement Date: June 26, 2026
Statement Time: 19:45:55
Company Code: 1795
Company Name: Mei-Shi Chemical Pharmaceutical Co., Ltd.
Subject: Announcement of Board Resolution to Cancel Fund Lending to Subsidiary Lotus International Pte. Ltd.
Applicable Clause: Item 51
Factual Date: June 26, 2026
Details:
1. Factual Date: June 26, 2026
2. Company Name: Mei-Shi Chemical Pharmaceutical Co., Ltd.
3. Relationship with Company: Parent Company
4. Cross-shareholding Ratio: 100%
5. Reason for Event: In alignment with the company's current operational status, the board has decided to cancel the previously approved USD 20 million fund lending limit to its subsidiary, Lotus International Pte. Ltd.
6. Countermeasures: Not applicable
7. Other Matters to be Disclosed: This announcement qualifies as material information under Article 7, Clause 9 of the Enforcement Rules of the Securities and Exchange Act, as the entity involved is a publicly listed company. However, there are no additional matters requiring disclosure that would significantly impact shareholder权益 or securities prices.
FAQ
Why did Mei-Shi cancel the fund lending?
To align with current operations and improve capital efficiency. No funds were disbursed, so no loss occurred.
Will this affect Mei-Shi's stock price?
The company states no significant impact on shareholder权益 or securities prices.
What happens to Lotus International now?
Operations continue, but future funding remains under review.